258 - Advancing the Management of Pediatric Community-Acquired Pneumonia

Saturday, October 19, 2024

3:15 PM – 4:30 PM US PT

Location: Petree C

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Angela Campbell, MD, MPH

Medical Officer
Coronavirus and Other Respiratory Viruses Division
Centers for Disease Control and Prevention
Atlanta, GA, United States
Lilliam Ambroggio, PhD (she/her/hers)

Associate Professor of Pediatrics
Children's Hospital Colorado
Aurora, CO, United States

Faculty(s)

Todd Florin, MD, MSCE

Associate Professor of Pediatrics
Department of Pediatrics, Northwestern University Feinberg School of Medicine
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, IL, United States
MG

Michelle Gill, MD, PhD (she/her/hers)

Homer E. Nash Jr., MD Endowed Chair in Pediatrics
Washington University School of Medicine
Saint Louis, MO, United States
Patrick M. Meyer Sauteur, MD PhD PD (Privatdozent) (he/him/his)

Consultant in Pediatric Infectious Diseases
University Children's Hospital Zurich, Switzerland
Zurich, Switzerland

Disclosure(s):

Angela P. Campbell, MD, MPH: No financial relationships to disclose

Lilliam Ambroggio, PhD: Pfizer, Inc.: Grant/Research Support (Ongoing)

Todd A. Florin, MD, MSCE: DiaSorin: Honoraria (Terminated, December 29, 2023)

Michelle Gill, MD, PhD: No financial relationships to disclose

Patrick M. Meyer Sauteur, MD PhD PD (Privatdozent): AstraZeneca: Advisor/Consultant (Terminated, June 9, 2022); Sanofi: Advisor/Consultant (Terminated, November 2, 2022)

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe applications of emerging diagnostic testing and risk stratification for pediatric community-acquired pneumonia;
investigate the latest scientific evidence and approach to management and treatment of pediatric community-acquired pneumonia;
recognize the challenges and approach to diagnosis and treatment of atypical bacteria focusing on mycoplasma pneumoniae.

Presentations:

3:15 PM – 3:40 PM US PT

Emerging Diagnostic Testing and Risk Stratification for Pediatric Community-Acquired Pneumonia
Speaker: Todd A. Florin, MD, MSCE – Ann & Robert H Lurie Children's Hospital of Chicago
3:40 PM – 4:05 PM US PT

What’s New with Management and Treatment of Pediatric Community-Acquired Pneumonia
Speaker: Michelle Gill, MD, PhD (she/her/hers) – Washington University School of Medicine
4:05 PM – 4:30 PM US PT

Challenges and Progress towards Diagnosis and Treatment of Infections with Mycoplasma pneumoniae
Speaker: Patrick M. Meyer Sauteur, MD PhD PD (Privatdozent) (he/him/his) – University Children's Hospital Zurich, Switzerland